Bioptik Technology Cash Flow Reinvestment Rate
Bioptik Technology cash flow reinvestment rate. Bioptik Technology (4161) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting NT$4.94 Million (capex NT$4.94 Million ) from operating cash flow of NT$53.21 Million. Explore Bioptik Technology cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Bioptik Technology (2017–2025)
Cash flow reinvestment rate of Bioptik Technology from 2017 to 2025. Historical reinvestment intensity for Bioptik Technology across 8 annual periods. Explore 4161 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Bioptik Technology Cash Flow Reinvestment Rate by Year (2017–2025)
Bioptik Technology cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Bioptik Technology. For the full cash flow conversion analysis, see Bioptik Technology operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | NT$39.23 Million | NT$59.99 Million | NT$22.80 Million | ▲ +481.8% |
| 2024 | 0.11x | NT$17.85 Million | NT$158.82 Million | NT$15.51 Million | ▼ -61.1% |
| 2023 | 0.29x | NT$59.58 Million | NT$205.95 Million | NT$31.04 Million | ▼ -92.8% |
| 2022 | 4.02x | NT$221.24 Million | NT$55.06 Million | NT$17.08 Million | ▼ -80.0% |
| 2020 | 20.13x | NT$132.29 Million | NT$6.57 Million | NT$13.18 Million | ▲ +214.2% |
| 2019 | 6.40x | NT$262.81 Million | NT$41.03 Million | NT$27.42 Million | ▲ +77.1% |
| 2018 | 3.62x | NT$151.22 Million | NT$41.83 Million | NT$50.96 Million | ▼ -78.0% |
| 2017 | 16.46x | NT$181.43 Million | NT$11.02 Million | NT$62.72 Million | — |